PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $451 | -52.3% | 14,707 | -37.7% | 0.00% | -50.0% |
| Q2 2023 | $946 | -1.5% | 23,615 | +0.4% | 0.01% | 0.0% |
| Q1 2023 | $960 | -55.3% | 23,517 | -57.7% | 0.01% | -74.2% |
| Q4 2022 | $2,147 | -99.8% | 55,614 | +225.8% | 0.03% | +158.3% |
| Q2 2022 | $995,000 | +35.9% | 17,069 | +40.2% | 0.01% | -20.0% |
| Q3 2020 | $732,000 | -34.2% | 12,173 | -50.4% | 0.02% | -28.6% |
| Q4 2019 | $1,113,000 | +24.5% | 24,567 | +4.7% | 0.02% | -32.3% |
| Q3 2019 | $894,000 | -57.1% | 23,473 | -51.1% | 0.03% | -62.7% |
| Q2 2019 | $2,086,000 | +522.7% | 47,958 | +516.0% | 0.08% | +245.8% |
| Q4 2018 | $335,000 | – | 7,786 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |